introduction to change management
FAKULTA INFORMATIKY A STATISTIKY
si Vás dovoluje pozvat
na mimořádnou přednášku kurzu 4IT528 Management of Enterprise IT
na které vystoupí výkonná ředitelka pro strategické plánování IT ze společnosti
Merck & Co., Inc. (v Evropě známé jako MSD) z New Jersey, USA
ANNE C. SPOLDI
INTRODUCTION TO CHANGE
která se koná v RB 212 dne 13. dubna 2015 od 11:00 do 13:00
Počet míst je omezen. Registrujte se co nejdříve na adrese:
Attend this interactive lecture to expand your knowledge about organizational change
management concepts and gain insight into what makes some transformations succeed and
others fail. Explore strategy execution with a focus on intent, people and delivery; discuss the
differences between installation and realization; and understand what's required to mobilize
commitment of change whether you work in a large enterprise or a start-up company.
Pre-read and other information: http://bit.ly/1yjl5tK .
ANNE C. SPOLDI
MERCK & CO., INC. (MSD)
Anne Spoldi is Executive Director, Merck IT
Planning and Realization. Anne leads the globally
communications enabling realization of Merck’s
multi-year IT strategy to drive business alignment,
growth, agility, and innovation.
As part of her
role, Anne leads a newly established IT-enabled
business modeling center of excellence focused on
opportunities to address unmet market needs and
create world-class organizational capability.
Anne joined Merck Global Services in 2009. Prior
to Merck, Anne was employed by Sun
Microsystems in Menlo Park, CA for over 10 years;
and led numerous cross organizational change
initiatives, executive development programs; and served in business development roles.
Earlier in her career, Anne worked for Perkin-Elmer, a life sciences instrumentation firm where
she held positions including marketing communications director and laboratory automation
product manager. Anne holds a B.S. in Biology/Chemistry from Sacred Heart University in
MSD is an innovative, global healthcare leader committed
to improving health and well-being in 140 countries
around the world. Our product categories include heart
and respiratory health, diabetes, infectious diseases,
consumer products and women's health. We continue to
focus our research on conditions that affect millions of
people around the world - diseases like Alzheimer's,
Diabetes and Cancer - while further expanding our
strengths in areas such as vaccines and
biologics. We aspire to be the best healthcare
company in the world and are dedicated to
providing innovative solutions for tomorrow.
MSD is known as Merck in the United States and Canada.